Cardio Diagnostics Inc.

Actionable Clinical Intelligence At Cardio Diagnostics Inc., our Epi+Gen CHD and PrecisionCHD tests are accompanied by our Actionable Clinical Intelligence? (ACI) platform. ACI is a clinician-facing platform that is exclusively available to clinicians using our Epi+Gen CHD? and PrecisionCHD? tests. ACI provides personalized insights to help with patient management by mapping each patient's unique genetic and epigenetic biomarkers to their modifiable drivers of coronary heart disease. With our tests and ACI, Precision Cardiovascular Medicine is now a reality.

Today is National Rural Health Day, a day to "bring attention to and honor the incredible efforts of rural healthcare providers, communities, organizations, State Offices of Rural Health, and other stakeholders dedicated to addressing the unique healthcare needs of rural America." Cardiovascular disease continues to be a major challenge in these areas, but innovation is creating real opportunities for change. Emerging technologies and new care models are improving access, enhancing prevention, and transforming treatment, helping to bridge the gap in rural healthcare. At Cardio Diagnostics Inc., our vision hasn’t changed and will remain the same: a world where heart disease is significantly reduced, and patients receive personalized care that improves outcomes and quality of life, regardless of their zip code. Learn more about the power of emerging technologies in Revolutionizing Rural Cardiovascular Care: https://lnkd.in/gQGGxVFc

We’re excited to be in Orlando as sponsors and exhibitors at Florida Association of ACOs (FLAACOs) 2024, showcasing our AI-powered cardiovascular solutions at booth #207. Our solutions are designed to help accountable care organizations (ACOs) reduce costs and improve care quality with personalized and precise insights into coronary heart disease that can seamlessly integrate into clinical workflows. Tomorrow, don’t miss our CEO and Co-Founder, Meesha Dogan, PhD., on the Strategic Innovation panel. She’ll discuss how AI and digital innovation are reshaping value-based care, helping ACOs drive better patient outcomes while managing costs. If you’re attending, stop by our booth to chat with our team and learn how our precision medicine solutions can empower your ACO with actionable insights for better, more precise care. ?? Learn more: https://lnkd.in/g6cQqNbr

This weekend, our team joined the #AHA24 here in Chicago, immersing ourselves in the latest innovations in heart health. We connected with thought leaders, partners, and collaborators, reinforcing how our AI-driven epigenetics-genetics solutions are paving the way for more personalized and precise cardiovascular care. We’re returning inspired to make an even greater impact in the fight against heart disease.

Even if you enjoy cooking, sometimes getting dinner on the table still seems like a chore. To make cooking more enjoyable, here are some simple, budget-friendly ideas to make your kitchen the most welcoming room at home.

At Cardio Diagnostics Inc., we believe in making medicine more personalized. Our epigenetics-based solutions enable providers to understand the modifiable drivers of heart disease so they can tailor the care plan to each patient. This means catching potential issues earlier and offering care that fits the unique health profile of each patient. Learn more about our innovative solutions at https://cdio.ai/.

We're excited to announce that we will be sponsoring and exhibiting at the upcoming Florida Association of ACOs (FLAACOs) 2024 Annual Fall Conference in Orlando, FL, from Nov 20-22. Join us at booth #207, where our team will showcase our AI-powered cardiovascular solutions designed to support accountable care organizations (ACOs) in delivering high-quality, cost-effective care. Our CEO and Co-Founder, Meesha Dogan, PhD., will speak on the Strategic Innovation panel, diving into how AI and digital innovation are advancing value-based care. If you're attending, we’d love to connect and discuss how our precision medicine solutions can empower ACOs to improve outcomes and manage costs effectively. ?? Learn more about FLAACOs 2024: FLAACOs 2024 Conference https://lnkd.in/g6cQqNbr

We’re #hiring a new Care Navigator and Billing Specialist in Chicago, Illinois. Apply today or share this post with your network.

We at Cardio Diagnostics Inc. honor the courage, resilience, and dedication of all who have served. Your sacrifices are a powerful testament to true service and commitment, qualities that inspire us every day in our mission to improve lives through personalized cardiovascular solutions. Today, we express our deepest gratitude and remember that the heart of innovation lies in serving others.

With the cooler months ahead, it’s easy to let our health take a backseat, but now more than ever, it’s important to stay proactive. At Cardio Diagnostics Inc., we are redefining cardiovascular care by leveraging the power of epigenetics, genetics, and AI to enable earlier risk assessment and detection of heart disease for more personalized care. Patients: Our personalized approach profiles a patient's unique genetic and epigenetic biomarkers to create a more comprehensive profile for coronary heart disease. Our tests are accessible remotely via telemedicine and at-home sampling or at a doctor's office. Providers: Enhanced diagnostic sensitivity and personalized molecular insights can lead to better care management for patients. Our solutions enable the shift from reactive healthcare to proactive prevention, ultimately improving outcomes and lowering the cost of care. To learn more about our solutions and make them accessible to your patients, schedule time with our provider partnerships leads, Nancy McHugh and Emily Sorg. ??